Genetic hunt for hidden causes of mysterious inflammatory diseases
NCT ID NCT06004349
First seen Jul 08, 2026 · Last updated Jul 09, 2026 · Updated 1 time
Summary
This study aims to better understand VEXAS syndrome and other autoinflammatory conditions by analyzing participants' DNA from blood, saliva, or skin samples. Researchers hope to discover new genetic variants that cause or contribute to these diseases. The study enrolls people of all ages with known or suspected autoinflammatory disorders, as well as healthy volunteers for comparison.
What this could mean
Our plain-language read of the trial. This is informational only — not medical advice or a prediction.
- What this could lead to
- If successful, this could uncover new genetic causes of inflammatory diseases, pointing toward better diagnosis or future treatments.
- What could go wrong
- This is an observational study, not a treatment trial. It may not directly lead to therapies, and genetic discoveries may take years to translate into clinical use.
This is an AI summary of the original study and may miss details. Read our disclaimer.
Get updates
Get notified about this study
Sign up to get updates when this study changes or when new studies for AUTOIMMUNE DISEASE are added.
By submitting, you agree to our Terms of use
Conditions
The condition(s) this trial relates to.
As listed by the trial registrant
The condition terms exactly as the trial's registrant entered them.
Contacts and locations
Show contact details
Enter your email to view the contact information for this study.
By submitting, you agree to our Terms of use
Study contacts
-
Contact
Phone: •••-•••-•••• Email: •••••@•••••
-
Contact
Phone: •••-•••-•••• Email: •••••@•••••
Locations
-
NYC H+H/Bellevue
RECRUITINGNew York, New York, 10016, United States
-
NYU Langone Health
RECRUITINGNew York, New York, 10016, United States
More trials for these conditions
Other studies related to the condition(s) this trial covers.
- Could shorter drug pauses before shoulder surgery reduce flares without raising infection risk?
- Biopsy tolerance study ends early – what we know
- Could a single injection reprogram immune cells to tame lupus and scleroderma?
- Your genes, your meds: 1200-Patient study tests smarter prescribing
- Could a stem cell transplant stop the immune system from attacking the brain?
- When to boost? new trial seeks best COVID-19 shot timing for vulnerable patients